Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Lilly is studying retatrutide in several phase 3 clinical trials to evaluate its potential efficacy and safety across several indications, including obesity and overweight with 1 weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
Yet with preclinical trials ongoing, the list of insurance-approved uses could soon expand to include sleep apnea (which can be weight-related), Parkinsons, dementia, and more
In the placenta, CRH-binding sites are expressed almost exclusively by the syncytiotrophoblast, and only CRH-R1 is found.194 CRH receptors are also present in the fetal membranes and myometrium
These medications mimic the GLP-1 hormone to support weight loss and blood sugar control
Smarter supplementation.
US$ 26.86
US$ 26.17
US$ 28.40
US$ 23.19
US$ 21.96
US$ 20.39
US$ 27.66
US$ 28.70
